The Maldives Food and Drug Authority (MFDA) has approved the Covid-19 vaccine developed by Moderna BioTech and the Covid-19 vaccine developed by the Janssen Pharmaceuticals Companies of Johnson & Johnson.
Announcing the approval today, MFDA said that the two vaccines were approved after technical considerations from the National Pharmaceutical Board, and are exclusively issued for restricted use in emergency Covid-19 pandemic, subject to various regulatory provisions.
Moderna mRNA-1273 Covid-19 vaccine is given in two doses in 4 weeks (or 28 days) apart. As per the World Health Organisation (WHO), the Moderna vaccine has been shown to have an efficacy of approximately 92% in protecting against COVID-19, starting 14 days after the first dose.
The Janssen Ad26.CoV2.S Covid-19 vaccine manufactured by the Janssen Pharmaceuticals Companies of Johnson & Johnson is given in one dose. As per WHO, 28 days after inoculation Janssen Ad26.CoV2.S was found to have an efficacy of 85.4% against severe disease and hospitalization, and a dose of Janssen Ad26.COV2.S was found in clinical trials to have an efficacy of 66.9% against symptomatic moderate and severe SARS-CoV-2 infection.
Both Moderna and the Janssen vaccines are recommended to use for people aged 18 and above. The WHO Strategic Advisory Group of Experts (SAGE) on Immunization has issued Interim recommendations for use of the Moderna and Janssen vaccines against COVID-19.
With Moderna BioTech and the Janssen Covid vaccines, Maldives has now approved 06 Covid-19 vaccines for emergency use. MFDA has already approved the Covishield vaccine developed by AstraZeneca and Oxford University, which is manufactured by the Serum Institute of India, China’s Sinopharm vaccine, Pfizer vaccine, and Russia’s Sputnik V Vaccine.
Announcing the approval today, MFDA said that the two vaccines were approved after technical considerations from the National Pharmaceutical Board, and are exclusively issued for restricted use in emergency Covid-19 pandemic, subject to various regulatory provisions.
Moderna mRNA-1273 Covid-19 vaccine is given in two doses in 4 weeks (or 28 days) apart. As per the World Health Organisation (WHO), the Moderna vaccine has been shown to have an efficacy of approximately 92% in protecting against COVID-19, starting 14 days after the first dose.
The Janssen Ad26.CoV2.S Covid-19 vaccine manufactured by the Janssen Pharmaceuticals Companies of Johnson & Johnson is given in one dose. As per WHO, 28 days after inoculation Janssen Ad26.CoV2.S was found to have an efficacy of 85.4% against severe disease and hospitalization, and a dose of Janssen Ad26.COV2.S was found in clinical trials to have an efficacy of 66.9% against symptomatic moderate and severe SARS-CoV-2 infection.
Both Moderna and the Janssen vaccines are recommended to use for people aged 18 and above. The WHO Strategic Advisory Group of Experts (SAGE) on Immunization has issued Interim recommendations for use of the Moderna and Janssen vaccines against COVID-19.
With Moderna BioTech and the Janssen Covid vaccines, Maldives has now approved 06 Covid-19 vaccines for emergency use. MFDA has already approved the Covishield vaccine developed by AstraZeneca and Oxford University, which is manufactured by the Serum Institute of India, China’s Sinopharm vaccine, Pfizer vaccine, and Russia’s Sputnik V Vaccine.
